Reversible conduction failure in anti-lactosylceramide-antibody-positive combined central and peripheral demyelination

Masaya Harada, Shiroh Miura, Hiroshi Kida, Taiga Moritaka, Ken Ichi Irie, Takashi Kamada, Yusuke Uchiyama, Sayuri Shima, Tatsuro Mutoh, Tomoaki Hoshino, Takayuki Taniwaki

研究成果: Article

抜粋

We describe a 60-year-old woman with combined central and peripheral demyelination who presented with obstinate constipation, weakness in the lower limbs, and a bilateral sensory disturbance below her chest followed by girdle sensation in the right region of the abdomen, which was responsive to steroid therapy and plasmapheresis. Serum anti-lactosylceramide antibody was positive without anti-neurofascin 155 antibody or anti-galactocerebroside antibody positivity. Two months later, the patient had a first relapse that was responsive to steroid treatment. A nerve conduction study confirmed reversible conduction failure (RCF) in both episodes. Our case is unique in that she had an RCF episode as well as some similarities to encephalomyeloradiculoneuropathy.

元の言語English
記事番号600
ジャーナルFrontiers in Neurology
10
発行部数JUN
DOI
出版物ステータスPublished - 2019

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

フィンガープリント Reversible conduction failure in anti-lactosylceramide-antibody-positive combined central and peripheral demyelination' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Harada, M., Miura, S., Kida, H., Moritaka, T., Irie, K. I., Kamada, T., Uchiyama, Y., Shima, S., Mutoh, T., Hoshino, T., & Taniwaki, T. (2019). Reversible conduction failure in anti-lactosylceramide-antibody-positive combined central and peripheral demyelination. Frontiers in Neurology, 10(JUN), [600]. https://doi.org/10.3389/fneur.2019.00600